arabinofuranosyluracil has been researched along with Colorectal Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akhurst, T; Balatoni, J; Banerjee, D; Bertino, JR; Blasberg, R; Doubrovin, M; Finn, R; Fong, Y; Gade, T; Gusani, NJ; Koutcher, JA; Larson, S; Mayer-Kuckuk, P; Tjuvajev, JG | 1 |
Alauddin, MM; Bading, JR; Bathija, P; Conti, PS; Fissekis, JD; Koda, RT; Koszalka, GW; Shahinian, AH; Vail, A | 1 |
Anderson, LW; Brown-Proctor, C; Collins, JM; Egorin, MJ; Eiseman, JL; Hamburger, DR; Joseph, E; Kinahan, PE; Klecker, RW; Mathis, CA; Pan, SS | 1 |
Collins, JM; Mangner, TJ; Muzik, O; Shields, AF; Sun, H | 1 |
1 trial(s) available for arabinofuranosyluracil and Colorectal Neoplasms
Article | Year |
---|---|
Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies.
Topics: Arabinofuranosyluracil; Bone Marrow; Breast Neoplasms; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Kidney; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Pilot Projects; Positron-Emission Tomography; Time Factors; Tissue Distribution | 2006 |
3 other study(ies) available for arabinofuranosyluracil and Colorectal Neoplasms
Article | Year |
---|---|
Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats.
Topics: Animals; Animals, Genetically Modified; Arabinofuranosyluracil; Cell Line, Tumor; Colorectal Neoplasms; Feasibility Studies; Folic Acid Antagonists; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Neoplasm Transplantation; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Nude; Recombinant Fusion Proteins; Tetrahydrofolate Dehydrogenase; Thymidine Kinase; Tissue Distribution; Transplantation, Heterologous; Viral Proteins; Whole-Body Counting | 2003 |
Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Carbon Radioisotopes; Cell Line, Tumor; Colorectal Neoplasms; DNA, Neoplasm; Female; Male; Metabolic Clearance Rate; Organ Specificity; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred F344; Thymidine; Tissue Distribution | 2004 |
Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
Topics: Animals; Arabinofuranosyluracil; Colorectal Neoplasms; DNA, Neoplasm; Female; Fluorouracil; HT29 Cells; Humans; Mice; Mice, SCID; Positron-Emission Tomography; Thymidylate Synthase; Time Factors; Tissue Distribution; Tritium; Xenograft Model Antitumor Assays | 2004 |